Ventive Hospitality, Carraro India, Senores Pharmaceuticals IPOs to open on Dec 20: All you need to know

Ventive Hospitality, Carros India, and Senores Pharmaceuticals' initial public offerings (IPOs) will open for subscription on Friday, December 20. The IPOs will conclude on Tuesday, December 24, and their allotment statuses are expected to be finalised on Thursday, December 26.

Shares of all three IPOs will be listed on the BSE and the NSE on Monday, December 30.

Ventive Hospitality IPO

Blackstone and Panchshil Realty-backed Ventive Hospitality IPO is exclusively a fresh issuance of 2.49 crore shares worth ₹1,600 crore.

The IPO proceeds will be used to repay certain borrowings and for general corporate purposes.

The price band has been set at ₹610 to ₹643 per share. An interested investor can bid for at least 23 shares, requiring an investment of ₹14,789.

The book-running lead managers for the issue are JM Financial, HSBC Securities and Capital Markets, Axis Capital, IIFL Securities, ICICI Securities, SBI Capital Markets, and Kotak Mahindra Capital, while the registrar is Kfin Technologies.

Carraro India IPO

The public offer of Carraro India, which manufactures transmission systems for tractors and off-highway vehicles, is entirely an offer for sale (OFS) of 1.78 crore shares worth ₹1,250 crore.

The price range has been fixed at ₹668 to ₹704 per share. Users can bid for a minimum application size of 21 shares, needing an investment of ₹14,784.

Carraro India is a technology-driven integrated supplier engaged in developing complex engineering products and solutions for original equipment manufacturers (OEMs), especially in the agricultural tractor and construction vehicle industries.

Senores Pharmaceuticals IPO

Senores Pharmaceuticals IPO consists of offering new shares worth ₹50 crore and an OFS of 21 lakh shares.

The company has yet to announce the price band.

Equirus Capital, Nuvama Wealth Management, and Ambit are the issue's book-running lead managers, while Link Intime India is the registrar.

Senores Pharmaceuticals develops and manufactures various pharmaceutical products for regulated markets of the United States, United Kingdom and Canada.

Its product portfolio includes hydroxychloroquine sulfate tablets, amphetamine sulfate tablets, ketoconazole tablets, butalbital, acetaminophen, and caffeine capsules, ketorolac tromethamine tablets, mexiletine hydrochloride capsules, and diclofenac potassium tablets.